Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
William C. Reisdorf, Neha Chhugani, Philippe Sanseau & Pankaj Agarwal. (2017) Harnessing public domain data to discover and validate therapeutic targets. Expert Opinion on Drug Discovery 12:7, pages 687-693.
Read now
Read now
Articles from other publishers (33)
Adetutu Akinnuwesi, Samuel Egieyeh & Ruben Cloete. (2023) State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach. Frontiers in Drug Discovery 3.
Crossref
Crossref
Aditi Chatterjee. (2023) Mycobacterium tuberculosis and its secreted tyrosine phosphatases. Biochimie 212, pages 41-47.
Crossref
Crossref
Rosanna Maccari & Rosaria Ottanà. (2023) Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine. International Journal of Molecular Sciences 24:11, pages 9621.
Crossref
Crossref
Sharda Shukla, R. Nishanth Rao, Harshavardhan Bhuktar, Rebecca Kristina Edwin, Trinath Jamma, Raghavender Medishetti, Sharmistha Banerjee, Varadaraj Bhat Giliyaru, Gautham G. Shenoy, Srinivas Oruganti, Parimal Misra & Manojit Pal. (2023) Wang resin catalysed sonochemical synthesis of pyrazolo[4,3-d]pyrimidinones and 2,3-dihydroquinazolin-4(1H)-ones: Identification of chorismate mutase inhibitors having effects on Mycobacterium tuberculosis cell viability. Bioorganic Chemistry 134, pages 106452.
Crossref
Crossref
Rajiv Gandhi Govindaraj, Sundar Thangapandian, Michael Schauperl, Rajiah Aldrin Denny & David J. Diller. (2023) Recent applications of computational methods to allosteric drug discovery. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Fisayo Olotu, Encarnacion Medina-Carmona, Angela Serrano-Sanchez, Felipe Ossa, Abdelaziz El-Hamdaoui, Özlem Tastan Bishop, Jose L. Ortega-Roldan & Vahitha B. Abdul-Salam. (2023) Structure-based discovery and in vitro validation of inhibitors of chloride intracellular channel 4 protein. Computational and Structural Biotechnology Journal 21, pages 688-701.
Crossref
Crossref
Amy Ryan, Chasity P. Janosko, Taylor M. Courtney & Alexander Deiters. (2022) Engineering SHP2 Phosphatase for Optical Control. Biochemistry 61:23, pages 2687-2697.
Crossref
Crossref
Hisham N. Altayb. (2022) Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach. Pharmaceuticals 15:9, pages 1129.
Crossref
Crossref
Tapan Behl, Amit Gupta, Aayush Sehgal, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, Saurabh Bhatia & Simona Bungau. (2022) Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus. Biomedicine & Pharmacotherapy 153, pages 113405.
Crossref
Crossref
Surendar Chitti, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Kevin Van Calster, Boddupalli Venkata Siva Kumar, Banoth Karan Kumar, Sankaranarayanan Murugesan, Davie Cappoen & Kondapalli Venkata Gowri Chandra Sekhar. (2022) Design, Synthesis and Biological Evaluation of Novel Spiro‐[Chroman‐2,4′‐Piperidin]‐4‐One Analogs as Anti‐Tubercular Agents. Chemistry & Biodiversity 19:8.
Crossref
Crossref
Angela Camila Orbem Menegatti. (2022) Targeting protein tyrosine phosphatases for the development of antivirulence agents: Yersinia spp. and Mycobacterium tuberculosis as prototypes. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1870:5, pages 140782.
Crossref
Crossref
Jyoti Prava & Archana Pan. (2022) In silico analysis of Leishmania proteomes and protein-protein interaction network: Prioritizing therapeutic targets and drugs for repurposing to treat leishmaniasis. Acta Tropica 229, pages 106337.
Crossref
Crossref
Muthu Kumar Thirunavukkarasu, Utid Suriya, Thanyada Rungrotmongkol & Ramanathan Karuppasamy. (2021) In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach. Pharmaceutics 14:1, pages 59.
Crossref
Crossref
Hani Choudhry. (2021) High-throughput screening to identify potential inhibitors of the Zα domain of the adenosine deaminase 1 (ADAR1). Saudi Journal of Biological Sciences 28:11, pages 6297-6304.
Crossref
Crossref
Chirasmita Nayak & Sanjeev Kumar Singh. (2021) In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells. PLOS ONE 16:10, pages e0255803.
Crossref
Crossref
Ying Yang, Lei Zhang, Jinying Tian, Fei Ye & Zhiyan Xiao. (2021) Integrated Approach to Identify Selective PTP1B Inhibitors Targeting the Allosteric Site. Journal of Chemical Information and Modeling 61:9, pages 4720-4732.
Crossref
Crossref
Homa MohammadiPeyhani, Anush Chiappino-Pepe, Kiandokht Haddadi, Jasmin Hafner, Noushin Hadadi & Vassily Hatzimanikatis. (2021) NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism. eLife 10.
Crossref
Crossref
Kasi Viswanatharaju Ruddraraju, Devesh Aggarwal & Zhong-Yin Zhang. (2020) Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis. Microorganisms 9:1, pages 14.
Crossref
Crossref
Javier García‐Marín, Mercedes Griera, Patricia Sánchez‐Alonso, Bruno Di Geronimo, Francisco Mendicuti, Manuel Rodríguez‐Puyol, Ramón Alajarín, Beatriz de Pascual‐Teresa, Juan J. Vaquero & Diego Rodríguez‐Puyol. (2020)
Pyrrolo[1,2‐
a
]quinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B
. ChemMedChem 15:19, pages 1788-1801.
Crossref
Crossref
Shun Ying Quah, Michelle Siying Tan, Kok Lian Ho, Nizar Abdul Manan, Alemayehu Abebe Gorfe, Pran Kishore Deb, Sreenivasa Rao Sagineedu & Johnson Stanslas. (2020)
In silico
and saturation transfer difference NMR approaches to unravel the binding mode of an andrographolide derivative to K-Ras oncoprotein
. Future Medicinal Chemistry 12:18, pages 1611-1631.
Crossref
Crossref
Mohammad A. Ghattas, Sara Al Rawashdeh, Noor Atatreh & Richard A. Bryce. (2020) How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study. Journal of Chemical Information and Modeling 60:8, pages 3901-3909.
Crossref
Crossref
Bigyan Sharma, Liuxing Xie, Fen Yang, Wei Wang, Quanming Zhou, Menghua Xiang, Shizhe Zhou, Wanting Lv, Yan Jia, Laxman Pokhrel, Jun Shen, Qicai Xiao, Liqian Gao & Wenbin Deng. (2020) Recent advance on PTP1B inhibitors and their biomedical applications. European Journal of Medicinal Chemistry 199, pages 112376.
Crossref
Crossref
Ana C.A. de Souza, Mattia Mori, Larissa Sens, Ruth F. Rocha, Tiago Tizziani, Luiz F.S. de Souza, Louise Domeneghini Chiaradia-Delatorre, Maurizio Botta, Ricardo J. Nunes, Hernán Terenzi & Angela C.O. Menegatti. (2020) A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia. Bioorganic & Medicinal Chemistry Letters 30:16, pages 127350.
Crossref
Crossref
Yurun Zhang, Martina Roos, Heather Himburg, Christina M. Termini, Mamle Quarmyne, Michelle Li, Liman Zhao, Jenny Kan, Tiancheng Fang, Xiao Yan, Katherine Pohl, Emelyne Diers, Hyo Jin Gim, Robert Damoiseaux, Julian Whitelegge, William McBride, Michael E. Jung & John P. Chute. (2019) PTPσ inhibitors promote hematopoietic stem cell regeneration. Nature Communications 10:1.
Crossref
Crossref
Dongfeng Zhang, Yun Lin, Xi Chen, Wenting Zhao, Dongni Chen, Meng Gao, Qinglin Wang, Bin Wang, Haihong Huang, Yongjun Lu & Yu Lu. (2019) Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold. Bioorganic Chemistry 85, pages 229-239.
Crossref
Crossref
George T. Lountos, Sreejith Raran-Kurussi, Bryan M. Zhao, Beverly K. Dyas, Terrence R. BurkeJrJr, Robert G. Ulrich & David S. Waugh. (2018) High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design. Acta Crystallographica Section D Structural Biology 74:10, pages 1015-1026.
Crossref
Crossref
Yanbo Tang, Xiaolin Zhang, Zheng Chen, Wenwen Yin, Guanglei Nan, Jinying Tian, Fei Ye & Zhiyan Xiao. (2018) Novel benzamido derivatives as PTP1B inhibitors with anti-hyperglycemic and lipid-lowering efficacy. Acta Pharmaceutica Sinica B 8:6, pages 919-932.
Crossref
Crossref
Daniel A Keedy, Zachary B Hill, Justin T Biel, Emily Kang, T Justin Rettenmaier, José Brandão-Neto, Nicholas M Pearce, Frank von Delft, James A Wells & James S Fraser. (2018) An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering. eLife 7.
Crossref
Crossref
Lingbo Fan, Xiaoyu Wu, Chunyan Jin, Fengge Li, Sidong Xiong & Yuanshu Dong. (2018) MptpB Promotes Mycobacteria Survival by Inhibiting the Expression of Inflammatory Mediators and Cell Apoptosis in Macrophages. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
John S. Lazo, Kelley E. McQueeney, James C. Burnett, Peter Wipf & Elizabeth R. Sharlow. (2018) Small molecule targeting of PTPs in cancer. The International Journal of Biochemistry & Cell Biology 96, pages 171-181.
Crossref
Crossref
Ammu Prasanna Kumar, Minh N. Nguyen, Chandra Verma & Suryani Lukman. (2018) Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites. Proteins: Structure, Function, and Bioinformatics 86:3, pages 301-321.
Crossref
Crossref
Alessandra Mascarello, Angela Camila Orbem Menegatti, Andrea Calcaterra, Priscila Graziela Alves Martins, Louise Domeneghini Chiaradia-Delatorre, Ilaria D'Acquarica, Franco Ferrari, Valentina Pau, Adriana Sanna, Alessandro De Logu, Maurizio Botta, Bruno Botta, Hernán Terenzi & Mattia Mori. (2018) Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B. European Journal of Medicinal Chemistry 144, pages 277-288.
Crossref
Crossref
Jonathan R. LaRochelle, Michelle Fodor, Jana M. Ellegast, Xiaoxi Liu, Vidyasiri Vemulapalli, Morvarid Mohseni, Travis Stams, Sara J. Buhrlage, Kimberly Stegmaier, Matthew J. LaMarche, Michael G. Acker & Stephen C. Blacklow. (2017) Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2. Bioorganic & Medicinal Chemistry 25:24, pages 6479-6485.
Crossref
Crossref